Franjic, D., Fountaine, R. J., Nalpas, C., Goswami, B., Fullerton, T. (2026). Efficacy and safety of rimegepant 75 mg orally disintegrating tablet for the acute treatment of chronic rhinosinusitis in adults: Results from a multicenter, randomized, placebo-controlled, phase 2/3 trial. PLoS ONE. https://doi.org/10.1371/journal.pone.0342907